Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn’s disease

doi:10.3748/wjg.v25.i14.1764

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7069)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-5) series.

Item

Count

PDF

457

WORD

172

HTML

3743

Figures (1-3)

336

Tables (1-5)

254

Sum=4962

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

779

Download

1328

Sum=2107

Apr 14, 2019 (publication date) through Jan 23, 2025

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Prospective Study

World J Gastroenterol. Apr 14, 2019; 25(14): 1764-1774
Published online Apr 14, 2019. doi: 10.3748/wjg.v25.i14.1764

Full Size Figure Download Figure

Figure 3 Receiver operating characteristics curves depicting the endoscopic response at week 14 as a predictor of mucosal healing after one year of anti- tumor necrosis factor treatment. Area under the curve = 0.778, P = 0.001; ROC: Receiver operating characteristics.

Citation: Alfaro I, Masamunt MC, Planell N, López-García A, Castro J, Gallego M, Barastegui R, Giner A, Vara A, Salas A, Ricart E, Panés J, Ordás I. Endoscopic response to tumor necrosis factor inhibitors predicts long term benefits in Crohn’s disease. World J Gastroenterol 2019; 25(14): 1764-1774
URL: https://www.wjgnet.com/1007-9327/full/v25/i14/1764.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i14.1764